INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
PLYMOUTH MEETING, Pa., March 26, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that Dr. Jacqueline Shea, President and CEO will participate in The Novel Therapeutics Forum hosted by Citizens JMP at Penn Medicine at 10:00 am ET on April 2, 2024.
賓夕法尼亞州普利茅斯會議，2024年3月26日 /PRNewswire/ — 專注於開發和商業化DNA藥物以幫助治療和保護人們免受人乳頭瘤病毒相關疾病、癌症和傳染病侵害的生物技術公司INOVIO（納斯達克股票代碼：INO）今天宣佈，總裁兼首席執行官傑奎琳·謝伊博士將參加美國東部時間2024年4月2日上午10點由Citizens JMP在賓夕法尼亞醫學院主辦的新型療法論壇。
Dr. Shea will provide a brief overview of INOVIO and then participate in a panel discussion entitled "Innovative Technologies for Treating and Preventing Disease," which will be moderated by Roy Buchanan, biotechnology analyst at Citizens JMP.
謝伊博士將簡要概述INOVIO，然後參加題爲 “治療和預防疾病的創新技術” 的小組討論，該討論將由Citizens JMP的生物技術分析師羅伊·布坎南主持。
The Citizens JMP Novel Therapeutics Forum will take place at the Jordan Medical Education Center at the Perelman Center for Advanced Medicine but will not be webcast.
Citizens JMP新型療法論壇將在佩雷爾曼先進醫學中心的約旦醫學教育中心舉行，但不會進行網絡直播。
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit .
關於 INOVIO
INOVIO是一家生物技術公司，專注於開發和商業化DNA藥物，以幫助治療和保護人們免受人乳頭瘤病毒相關疾病、癌症和傳染病的侵害。INOVIO的技術優化了創新DNA藥物的設計和交付，這些藥物可以教導人體制造自己的抗病工具。欲了解更多信息，請訪問。
Contacts
Media: Jennie Willson (267) 429-8567 [email protected]
Investors: Thomas Hong (267) 440-4298 [email protected]
聯繫人
媒體：珍妮·威爾森 (267) 429-8567 [email protected]
投資者：托馬斯·洪 (267) 440-4298 [email protected]
SOURCE INOVIO Pharmaceuticals, Inc.
來源 INOVIO 製藥公司